Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Genome Therapeutics, Amgen Collaborate On Bone Diseases

Jan. 3, 2003

By Aaron Lorenzo

Genome Therapeutics, Amgen Collaborate On Bone Diseases

Jan. 3, 2003

By Aaron Lorenzo

Cellegy Enters Deal With PDL For Marketing Of Tostrex Gel

Jan. 3, 2003

By Aaron Lorenzo

ChemoCentryx Focuses Efforts On Targeting Chemokine System

Jan. 2, 2003

By Aaron Lorenzo

ChemoCentryx Focuses Efforts On Targeting Chemokine System

Jan. 2, 2003

By Aaron Lorenzo

Amphora Adds $23M In Series B To Carry Out Discovery Programs

Dec. 31, 2002

By Aaron Lorenzo

Amphora Adds $23M In Series B To Carry Out Discovery Programs

Dec. 31, 2002

By Aaron Lorenzo

BioRexis Completes Series A Round For Peptides, Antibodies

Dec. 30, 2002

By Aaron Lorenzo

BioRexis Completes Series A Round For Peptides, Antibodies

Dec. 30, 2002

By Aaron Lorenzo

Transave Raises $12M For Work Targeting Diseases Of The Lung

Dec. 27, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...